← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT06706765

NCT06706765 Group Telehealth Behavioral Cough Suppression Therapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06706765
Status Recruiting
Phase EARLY_Phase 1
Sponsor University of Montana
Condition Refractory Chronic Cough
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-03-22
Primary Completion 2025-01-31

Trial Parameters

Condition Refractory Chronic Cough
Sponsor University of Montana
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-03-22
Completion 2025-01-31
Interventions
Behavioral Treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Eligibility Criteria

Inclusion Criteria: * At least 18 years old * Predominantly dry cough for at least 8 weeks * Evaluated and treated by at least one physician for cough * Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results * Access to a computer or tablet that includes a camera and able to use the device independently * Reliable internet access * Willing to agree to maintain confidentiality of personal information (including names) related to others in the study Exclusion Criteria: * Under age 18 * Coughing up blood * Current smoker of any substance * History of smoking or 10 or more years * Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma but they have not had any formal lung testing and asthma treatments have not helped your cough, we don't consider this a formal asthma diagnosis and wil

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology